home company solutions partners contact
Search
   
  About Logos Technologies
Logos Technologies is a leading provider of world-class integrated clinical trial solutions to the world’s pharmaceutical, biotechnology and clinical research organisations.   Logos Technologies help their clients accelerate research and development and thereby reduce the development time of life saving and life enhancing drugs. The ALPHADAS Suite is a clinical study management and fully mobile Phase I EDC system. The main benefits of the system provide a reliable, portable solution for EDC, integrate clinical and laboratory operations, accelerate data throughput and enhance data integrity. ALPHADAS also improves compliance with the regulatory authorities by providing a systematic process to facilitate Data Management and QA review.  Logos Technologies established and proven product ALPHADAS is beginning to set the standard in collecting Phase I clinical trial data
 
ELECTRONIC DATA CAPTURE
A Global Strategic Business Report,  October 2006

 

This report analyzes the worldwide markets for Electronic Data Capture in US$ Million. The report provides separate comprehensive analytics for the United States and Rest of World. Annual forecasts are provided for the period of 2002 through 2010. The report profiles 51 companies including many key and niche players worldwide such as Axiope, DataLabs, DATATRAK International, Inc., eResearchTechnology, Inc., etrials 

 

Worldwide, Inc., Intrasphere, IT Soft Corporation, LifeTree eClinical, Logos Technologies, Medidata Solutions Worldwide, Inc., MedNet Solutions, Nextrials, Ninaza, OmniComm Systems, Inc., Oracle, Phase Forward, and Phoenix Data Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

 

 http://www.strategyr.com/MCP-1721.asp

 

 

 
 
 
       
     
HOME COMPANY SOLUTIONS PARTNERS NEWS & EVENTS CONTACT
Copyright 2004 Logos technologies. All rights reserved. Privacy statement.